Home › Funds › MPM BioImpact LLC › QURE
MPM BioImpact LLC position in QURE
UNIQURE NV · Health Care
MPM BioImpact LLC reported holding 1,225,855 shares of QURE (UNIQURE NV) in its Q2 2026 13F filing — a position valued at US$56.5M, representing 3.44% of its reported portfolio and ranking #11 among its reported holdings. MPM BioImpact LLC has disclosed QURE holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MPM BioImpact LLC's QURE position evolved
MPM BioImpact LLC first disclosed a stake in QURE in Q4 2025 at 1,381,628 shares (US$33.1M). The position peaked in Q2 2026 at 1,225,855 shares, worth US$56.5M. Across 3 filings, MPM BioImpact LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,225,855 shares valued at US$56.5M — a reduction of -143,376 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.38M | $33.06M | New |
| Q1 2026 | 1.37M | $22.39M | Reduce |
| Q2 2026 | 1.23M | $56.46M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QURE and 13F data
QURE (UNIQURE NV) is a Health Care company. 64 other funds we track also report a position in QURE — the largest reported positions include Avoro Capital Advisors LLC (US$309.9M), RTW INVESTMENTS, LP (US$181.5M), ORBIMED ADVISORS LLC (US$83.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QURE
- Avoro Capital Advisors LLC 6.73M sh · $309.88M · Q2 2026
- RTW INVESTMENTS, LP 3.94M sh · $181.55M · Q2 2026
- ORBIMED ADVISORS LLC 1.81M sh · $83.25M · Q2 2026
- Boxer Capital Management, LLC 1.50M sh · $69.24M · Q2 2026
- MAK CAPITAL ONE LLC 1.23M sh · $56.75M · Q2 2026
- Vestal Point Capital, LP 935.00K sh · $43.07M · Q2 2026
- Maverick Capital 925.38K sh · $42.62M · Q2 2026
- MAVERICK CAPITAL LTD 925.38K sh · $42.62M · Q2 2026
- Integral Health Asset Management, LLC 900.00K sh · $41.45M · Q2 2026
- Longaeva Partners L.P. 804.59K sh · $37.06M · Q2 2026
- Two Seas Capital LP 1.32M sh · $31.99M · Q3 2026
- First Turn Management, LLC 608.92K sh · $28.05M · Q2 2026
More on MPM BioImpact LLC
FAQ
How long has MPM BioImpact LLC held QURE?
MPM BioImpact LLC has disclosed QURE holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is MPM BioImpact LLC's current position in QURE?
As of Q2 2026, MPM BioImpact LLC holds 1.23M shares of QURE (UNIQURE NV), valued at $56.46M, representing 3.44% of its reported portfolio and ranking #11.
Has MPM BioImpact LLC been buying or selling QURE?
In the latest 13F filing (Q2 2026), MPM BioImpact LLC reduced its position in QURE. The position peaked in Q2 2026 at 1.23M shares.
Which other funds hold QURE?
Other major institutional holders of QURE include Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, ORBIMED ADVISORS LLC, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.